ATE449175T1 - Bakterielle produktion von interferon-beta polypeptiden - Google Patents

Bakterielle produktion von interferon-beta polypeptiden

Info

Publication number
ATE449175T1
ATE449175T1 AT96919131T AT96919131T ATE449175T1 AT E449175 T1 ATE449175 T1 AT E449175T1 AT 96919131 T AT96919131 T AT 96919131T AT 96919131 T AT96919131 T AT 96919131T AT E449175 T1 ATE449175 T1 AT E449175T1
Authority
AT
Austria
Prior art keywords
interferon
beta polypeptides
bacterial production
beta
production
Prior art date
Application number
AT96919131T
Other languages
English (en)
Inventor
Glenn Dorin
Patrick J Mcalary
Kathleen M Wong
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of ATE449175T1 publication Critical patent/ATE449175T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96919131T 1995-06-06 1996-06-05 Bakterielle produktion von interferon-beta polypeptiden ATE449175T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/477,310 US5814485A (en) 1995-06-06 1995-06-06 Production of interferon-β (IFN-β) in E. coli
PCT/US1996/009155 WO1996039523A2 (en) 1995-06-06 1996-06-05 Bacterial production of hydrophobic polypeptides

Publications (1)

Publication Number Publication Date
ATE449175T1 true ATE449175T1 (de) 2009-12-15

Family

ID=23895395

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919131T ATE449175T1 (de) 1995-06-06 1996-06-05 Bakterielle produktion von interferon-beta polypeptiden

Country Status (17)

Country Link
US (1) US5814485A (de)
EP (1) EP0778893B1 (de)
JP (3) JP4131554B2 (de)
AT (1) ATE449175T1 (de)
AU (1) AU6154996A (de)
BR (1) BR9606491A (de)
CA (1) CA2195799C (de)
DE (1) DE69638077D1 (de)
FI (1) FI970445L (de)
IL (1) IL120009A0 (de)
IN (1) IN190514B (de)
MX (1) MX9700818A (de)
MY (1) MY118492A (de)
NO (1) NO324529B1 (de)
NZ (1) NZ310710A (de)
TW (1) TW494138B (de)
WO (1) WO1996039523A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997048808A1 (en) * 1996-06-19 1997-12-24 Chiron Corporation Bacterial production of interferon-beta using low levels of sodium and potassium ions
US6514729B1 (en) 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
RU2180687C1 (ru) * 2000-07-05 2002-03-20 Общество с ограниченной ответственностью "Биотех" Штамм дрожжей pichia pastoris - продуцент фибробластного интерферона человека, рекомбинантная плазмидная днк phif и способ ее конструирования
US7544354B2 (en) * 2000-10-27 2009-06-09 Novartis Vaccines And Diagnostics Methods of protein purification and recovery
WO2002042336A2 (en) * 2000-11-21 2002-05-30 The Texas A & M University System Fgf-affinity chromatography
NZ525597A (en) * 2000-11-29 2004-11-26 Morinaga Milk Industry Co Ltd Interferon therapeutic effect-potentiating agents
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
UY27373A1 (es) * 2001-07-09 2003-02-28 Schering Ag Formulaciones de interferón beta-humano
DE60332358D1 (de) * 2002-09-09 2010-06-10 Hanall Pharmaceutical Co Ltd Protease-resistente modifizierte interferon alpha polypeptide
RU2006104023A (ru) * 2003-07-11 2006-07-27 Шеринг Акциенгезельшафт (De) УЛУЧШЕННЫЕ РЕКОМБИНАНТНЫЕ ПОЛИПЕПТИДЫ ЧЕЛОВЕЧЕСКОГО ИНТЕРФЕРОНА -БЕТА-1b
US7846427B2 (en) * 2003-12-11 2010-12-07 Ares Trading S.A. Stabilized interferon liquid formulations
US8778880B2 (en) 2004-02-02 2014-07-15 Ambrx, Inc. Human growth hormone modified at position 35
WO2006122971A2 (en) * 2005-05-19 2006-11-23 Bayer Schering Pharma Aktiengesellschaft Treatment of disease using an improved regulated expression system
US20080076729A1 (en) * 2005-05-19 2008-03-27 Schering Aktiengesellachaft Interferon-beta gene therapy using an improved, regulated expression system
EP1891224A1 (de) * 2005-05-19 2008-02-27 Bayer Schering Pharma Aktiengesellschaft Interferon-beta-gentherapie unter verwendung eines verbesserten, regulierten expressionssystems
US20070179113A1 (en) * 2005-05-19 2007-08-02 Schering Aktiengesellachaft GM-CSF gene therapy for Crohn's disease using an improved regulated expression system
WO2007110231A2 (en) * 2006-03-28 2007-10-04 Nautilus Biotech, S.A. MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES
WO2008130382A2 (en) 2006-10-31 2008-10-30 East Carolina University Fusion proteins comprising an anti -inflammatory cytokine and an antigen for treatment of immune disorders
WO2008125222A2 (en) * 2007-04-11 2008-10-23 Bayer Schering Pharma Aktiengesellschaft New modulation molecules for an improved regulated expression system
EP2076533B1 (de) 2007-05-02 2014-10-08 Ambrx, Inc. Modifizierte interferon-beta-polypeptide und ihre verwendungen
EP2207890A4 (de) * 2007-10-05 2010-12-15 Barofold Inc Hochdruckbehandlung aggregierter interferone
ES2387236T3 (es) * 2007-12-20 2012-09-18 Merck Serono S.A. Formulaciones de interferón beta pegilado
US9938333B2 (en) 2008-02-08 2018-04-10 Ambrx, Inc. Modified leptin polypeptides and their uses
KR20090124204A (ko) * 2008-05-29 2009-12-03 (주)바이오큐어팜 아미노 말단의 메티오닌이 제거된 재조합 사람 변이인터페론-베타 단백질을 생산하는 재조합 대장균 및 이의제조방법
AU2010234743A1 (en) 2009-03-31 2011-10-20 East Carolina University Cytokines and neuroantigens for treatment of immune disorders
BR112012018956B1 (pt) * 2010-02-01 2022-05-31 Digna Biotech, S.L. Processo para produção de uma proteína interferon alfa 5
EP2542574B1 (de) 2010-03-04 2017-08-09 Pfenex Inc. Verfahren zur herstellung eines löslichen und rekombinanten interferonproteins ohne denaturierung
RU2473696C1 (ru) * 2011-07-14 2013-01-27 Закрытое акционерное общество "ГЕНЕРИУМ" ПРОМЫШЛЕННЫЙ СПОСОБ ПОЛУЧЕНИЯ И ОЧИСТКИ РЕКОМБИНАНТНОГО ИНТЕРФЕРОНА β-1b ЧЕЛОВЕКА ИЗ ТЕЛЕЦ ВКЛЮЧЕНИЯ
JP6363326B2 (ja) * 2013-03-11 2018-07-25 株式会社コーセー 酵母・細菌共通培養方法およびこれに用いる酵母・細菌共通培養培地
JP7151049B2 (ja) * 2018-03-30 2022-10-12 三井化学株式会社 微生物を増殖させる方法
JP2023159758A (ja) * 2022-04-20 2023-11-01 東ソー株式会社 遺伝子組換え大腸菌を用いたタンパク質の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499188A (en) * 1982-05-05 1985-02-12 Cetus Corporation Bacterial production of heterologous polypeptides under the control of a repressible promoter-operator
IE56026B1 (en) * 1982-10-19 1991-03-27 Cetus Corp Cysteine-depleted muteins of biologically active proteins
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4656132A (en) * 1984-03-28 1987-04-07 Cetus Corporation Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
JPH0755152B2 (ja) * 1986-06-02 1995-06-14 日本化薬株式会社 組換え遺伝子産物の製法及び培地

Also Published As

Publication number Publication date
JP4131554B2 (ja) 2008-08-13
JP2008283988A (ja) 2008-11-27
FI970445A7 (fi) 1997-03-26
IN190514B (de) 2003-08-02
DE69638077D1 (de) 2009-12-31
NO970514L (no) 1997-03-17
JP2008086331A (ja) 2008-04-17
IL120009A0 (en) 1997-04-15
JPH11501820A (ja) 1999-02-16
TW494138B (en) 2002-07-11
WO1996039523A2 (en) 1996-12-12
BR9606491A (pt) 1997-09-02
MX9700818A (es) 1997-05-31
JP4317890B2 (ja) 2009-08-19
AU6154996A (en) 1996-12-24
US5814485A (en) 1998-09-29
NZ310710A (en) 1999-01-28
FI970445A0 (fi) 1997-02-03
CA2195799C (en) 2010-02-09
NO324529B1 (no) 2007-11-12
WO1996039523A3 (en) 1997-01-30
EP0778893A2 (de) 1997-06-18
FI970445L (fi) 1997-03-26
EP0778893B1 (de) 2009-11-18
MY118492A (en) 2004-11-30
NO970514D0 (no) 1997-02-05
CA2195799A1 (en) 1996-12-12

Similar Documents

Publication Publication Date Title
ATE449175T1 (de) Bakterielle produktion von interferon-beta polypeptiden
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
YU45871B (sh) Polipeptid sa humanim imunointerferonskim (ifn-gama) svojstvima
BR9508981A (pt) Mutantes de subtilisina isentos de cálcio
ATE274577T1 (de) Stammzellen-proliferations-faktor
ES8706443A1 (es) Un procedimiento para preparar una solucion parenteral de activador de plasminogeno de tejido (t-pa)
ATE167518T1 (de) Zellzyklusprotein in säugetieren
DE69702705D1 (de) Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzieren
FI925988A0 (fi) Foerfarande foer framstaellning av b-laktamer
SE8801701D0 (sv) Production technology based on enzymic method
ATE346144T1 (de) Enzym mit galaktanaseaktivität
AU569896B2 (en) Process for the dissolution of peptides and proteins
FR2665168B1 (fr) Composition comportant un succinoglycane.
PT935652E (pt) Produtos de factor de crescimento de queratinocitos-2
ES2052513T3 (es) Nuevos polipeptidos, su fabricacion y empleo.
BR9407357A (pt) Novos tripeptideos utilizáveis em terapia cns e imune
ATE288476T1 (de) Herstellung von proteinen
DE59611293D1 (de) Protein mit dnase-aktivität
DE3783425D1 (de) Mikroorganismen, die fremdproteinenthaltende pili tragen, isolierte pili, verfahren zur ausscheidung von proteinen in verwendung dieser pili und deren nutzen.
ES8502162A1 (es) Procedimiento para preparar un hidrolizado proteinico
GR3003950T3 (de)
TH43244A (th) การสร้างพอลิเพพไทด์ไม่ชอบน้ำโดยแบคทีเรีย
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
DE59610098D1 (de) Protein mit anti-tumorwirkung
ITMI910861A1 (it) Procedimento migliorato per la preparazione di polipeptidi maturi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties